Juan Carlos Andreu-Ballester

8PUBLICATIONS
19CO-AUTHORS
Cancer cell biologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)AllergyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
Downregulation of CD132 in Colonic Adenomas and Cancer Is Associated with γδ T-Cell Loss, Increased Apoptosis, and Microsporidia Infection.

|Jul 28, 2026
SARS-CoV-2 mRNA Vaccination Induces Reduced T-Cell Apoptosis in Patients with Solid Tumors.

|May 04, 2026
Dysregulated IL-7/IL-7R-CD132 Axis and Intestinal Microsporidiosis in Crohn's Disease.

|Aug 28, 2025
Prevalence of Anti-Anisakis simplex Antibodies in a Cohort of Patients with Inflammatory Bowel Disease in Norway.

María P de la Hoz-Martín, Juan González-Fernández, Juan Carlos Andreu-Ballester

|Dec 27, 2024
Increased Levels of Anti-Anisakis Antibodies During Hospital Admission in Septic Patients.

Juan Carlos Andreu-Ballester, Amparo Navarro, Miguel Angel Arribas

|May 25, 2024
A Low Number of Baselines γδ T Cells Increases the Risk of SARS-CoV-2 Post-Vaccination Infection.

Juan Carlos Andreu-Ballester, Lorena Galindo-Regal, Carmen Cuéllar

Pageof 2

Frequent Collaborators

5 joint publications

Carmen Cuéllar

3 joint publications

Lorena Galindo-Regal

2 joint publications

María Leonor Fernández-Murga

2 joint publications

Antonio Llombart-Cussac